Anthony offers insights with Endpoints News

In early April, Endpoints News published “Avoiding Cell Therapy Manufacturing Gridlocks — a Do’s and Don’ts Guide,” in which guidance by our CEO, Anthony Davies, figured prominently. (One of his many quotes is above in the header on this page.)…

Read More »
Katy Spink Managing Partner smiling across from Anthony Davies CEO

CEO Davies and COO Spink featured in In Vivo article

Solutions Exist To Regenerative Medicine’s Most Pressing Manufacturing Challenges Exploring Cell And Gene Therapy Manufacturing And Logistic Issues

published 16 Mar 2021 at written by Amanda Micklusreproduced with permission

PDF available for download, here

Regenerative medicines have made significant advancements in …

Read More »
CEO Anthony Davies welcomes us to the super-plenary at Phacilitate in Miami in Jan of 2020

Davis and BioProcess Int’l: a reality check

Cell and Gene Therapies Get a Reality Check: A Conversation with Anthony Davies of Dark Horse Consulting Group

As founder of cell and gene therapy (CGT) specialist firm Dark Horse Consulting Group in California, Anthony Davies speaks from a quarter …

Read More »

We use cookies to help give you the best experience on our website. By continuing you agree to our use of cookies.